ELTX
Price
$7.90
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
125.58M
LVTX
Price
$1.31
Change
+$0.02 (+1.54%)
Updated
Jun 27 closing price
Capitalization
34.46M
58 days until earnings call
Interact to see
Advertisement

ELTX vs LVTX

Header iconELTX vs LVTX Comparison
Open Charts ELTX vs LVTXBanner chart's image
Elicio Therapeutics
Price$7.90
Change-$0.00 (-0.00%)
Volume$43.28K
Capitalization125.58M
LAVA Therapeutics
Price$1.31
Change+$0.02 (+1.54%)
Volume$11.96K
Capitalization34.46M
ELTX vs LVTX Comparison Chart in %
Loading...
ELTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELTX vs. LVTX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELTX is a Buy and LVTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ELTX: $7.90 vs. LVTX: $1.32)
Brand notoriety: ELTX and LVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELTX: 92% vs. LVTX: 37%
Market capitalization -- ELTX: $125.58M vs. LVTX: $34.46M
ELTX [@Biotechnology] is valued at $125.58M. LVTX’s [@Biotechnology] market capitalization is $34.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELTX’s FA Score shows that 1 FA rating(s) are green whileLVTX’s FA Score has 1 green FA rating(s).

  • ELTX’s FA Score: 1 green, 4 red.
  • LVTX’s FA Score: 1 green, 4 red.
According to our system of comparison, ELTX is a better buy in the long-term than LVTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELTX’s TA Score shows that 6 TA indicator(s) are bullish while LVTX’s TA Score has 4 bullish TA indicator(s).

  • ELTX’s TA Score: 6 bullish, 5 bearish.
  • LVTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ELTX and LVTX are a good buy in the short-term.

Price Growth

ELTX (@Biotechnology) experienced а -1.86% price change this week, while LVTX (@Biotechnology) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

LVTX is expected to report earnings on Aug 26, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELTX($126M) has a higher market cap than LVTX($34.5M). ELTX YTD gains are higher at: 54.902 vs. LVTX (38.276). LVTX has higher annual earnings (EBITDA): -26.26M vs. ELTX (-49.52M). LVTX has more cash in the bank: 66.6M vs. ELTX (18.4M). LVTX has less debt than ELTX: LVTX (312K) vs ELTX (5.79M). LVTX has higher revenues than ELTX: LVTX (4.99M) vs ELTX (0).
ELTXLVTXELTX / LVTX
Capitalization126M34.5M365%
EBITDA-49.52M-26.26M189%
Gain YTD54.90238.276143%
P/E Ratio5.96N/A-
Revenue04.99M-
Total Cash18.4M66.6M28%
Total Debt5.79M312K1,856%
TECHNICAL ANALYSIS
Technical Analysis
ELTXLVTX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
72%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ELTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALFFF0.80N/A
N/A
Alfa S.A.B de C.V
NRPI0.08N/A
N/A
NRP Stone, Inc.
PCHM3.71N/A
N/A
PharmChem, Inc.
PTCHF1.75N/A
N/A
PureTech Health PLC
WRFRF2.85-0.24
-7.70%
Wharf Real Estate Investment Co Ltd.

ELTX and

Correlation & Price change

A.I.dvisor tells us that ELTX and CORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELTX and CORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELTX
1D Price
Change %
ELTX100%
N/A
CORT - ELTX
29%
Poorly correlated
-1.49%
PCVX - ELTX
28%
Poorly correlated
-0.91%
HNSBF - ELTX
27%
Poorly correlated
N/A
PRRUF - ELTX
27%
Poorly correlated
N/A
LVTX - ELTX
27%
Poorly correlated
+0.77%
More

LVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LVTX has been loosely correlated with JBPHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LVTX jumps, then JBPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVTX
1D Price
Change %
LVTX100%
+0.77%
JBPHF - LVTX
38%
Loosely correlated
N/A
TCRX - LVTX
34%
Loosely correlated
-5.41%
OPORF - LVTX
32%
Poorly correlated
N/A
CRBU - LVTX
29%
Poorly correlated
-5.19%
CRVO - LVTX
28%
Poorly correlated
-14.85%
More